181 related articles for article (PubMed ID: 28872911)
61. [Multi-center survey of edaravone treatment in children].
Yamamoto H; Hayashi M
No To Hattatsu; 2008 Jul; 40(4):333-4. PubMed ID: 18634421
[No Abstract] [Full Text] [Related]
62. [Outcome assessment in treatment of edaravone in childhood ischemic stroke].
Osaka H; Okazaki S
No To Hattatsu; 2008 Sep; 40(5):403-5. PubMed ID: 18807890
[No Abstract] [Full Text] [Related]
63. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator.
Lapchak PA; Zivin JA
Exp Neurol; 2009 Jan; 215(1):95-100. PubMed ID: 18851964
[TBL] [Abstract][Full Text] [Related]
64. The novel antioxidant edaravone: from bench to bedside.
Watanabe T; Tahara M; Todo S
Cardiovasc Ther; 2008; 26(2):101-14. PubMed ID: 18485133
[TBL] [Abstract][Full Text] [Related]
65. Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury.
Shakkour Z; Issa H; Ismail H; Ashekyan O; Habashy KJ; Nasrallah L; Jourdi H; Hamade E; Mondello S; Sabra M; Zibara K; Kobeissy F
Curr Med Chem; 2021; 28(12):2369-2391. PubMed ID: 32787753
[TBL] [Abstract][Full Text] [Related]
66. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction.
Tsujita K; Shimomura H; Kawano H; Hokamaki J; Fukuda M; Yamashita T; Hida S; Nakamura Y; Nagayoshi Y; Sakamoto T; Yoshimura M; Arai H; Ogawa H
Am J Cardiol; 2004 Aug; 94(4):481-4. PubMed ID: 15325934
[TBL] [Abstract][Full Text] [Related]
67. Efficacy, safety, and outcomes in 17 pediatric cases treated with the free radical scavenger edaravone.
Nakamoto H; Aihara Y; Yamaguchi K; Kawamata T; Okada Y
Childs Nerv Syst; 2015 Sep; 31(9):1533-40. PubMed ID: 26206114
[TBL] [Abstract][Full Text] [Related]
68. The pathogenesis of ALS: implications for treatment strategies.
Silani V; Braga M; Cardin V; Scarlato G
Neurol Neurochir Pol; 2001; 35(1 Suppl):25-39. PubMed ID: 11732278
[TBL] [Abstract][Full Text] [Related]
69. The therapeutic efficacy of edaravone in extensively burned rats.
Koizumi T; Tanaka H; Sakaki S; Shimazaki S
Arch Surg; 2006 Oct; 141(10):992-5. PubMed ID: 17043277
[TBL] [Abstract][Full Text] [Related]
70. [The protective effect of edaravone on the treatment of sepsis in rats].
Shi M; Cao TW; Shen L; Sun ZD; Zhu HC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Dec; 21(12):747-8. PubMed ID: 20042144
[No Abstract] [Full Text] [Related]
71. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
de Carvalho M; Swash M
Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
[TBL] [Abstract][Full Text] [Related]
72. Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis.
Moriya M; Nakatsuji Y; Miyamoto K; Okuno T; Kinoshita M; Kumanogoh A; Kusunoki S; Sakoda S
Neurosci Lett; 2008 Aug; 440(3):323-6. PubMed ID: 18579300
[TBL] [Abstract][Full Text] [Related]
73. Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access: expert panel recommendations.
Barrington CJ; Burruano M; Carney C; Choi J; Januska J; Lachuk L; Oskarsson B; Rodriguez C; Speicher L; Tereso G
Am J Manag Care; 2021 Aug; 27(12 Suppl):S231-S237. PubMed ID: 34382759
[TBL] [Abstract][Full Text] [Related]
74. Effect of free radical scavenger, edaravone, for patients with carbon monoxide poisoning.
Mori K; Beppu T; Fujisawa Y; Onodera M; Ogasawara K; Sasaki M; Ehara S; Sakai A; Endo S
Clin Neurol Neurosurg; 2015 Dec; 139():56-61. PubMed ID: 26368269
[TBL] [Abstract][Full Text] [Related]
75. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
Zhang W; Sato K; Hayashi T; Omori N; Nagano I; Kato S; Horiuchi S; Abe K
Neurol Res; 2004 Apr; 26(3):342-8. PubMed ID: 15142331
[TBL] [Abstract][Full Text] [Related]
76. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
Kikuchi K; Tancharoen S; Matsuda F; Biswas KK; Ito T; Morimoto Y; Oyama Y; Takenouchi K; Miura N; Arimura N; Nawa Y; Meng X; Shrestha B; Arimura S; Iwata M; Mera K; Sameshima H; Ohno Y; Maenosono R; Tajima Y; Uchikado H; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I; Kawahara K
Biochem Biophys Res Commun; 2009 Dec; 390(4):1121-5. PubMed ID: 19737535
[TBL] [Abstract][Full Text] [Related]
77. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
[TBL] [Abstract][Full Text] [Related]
78. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
Wu HY; Tang Y; Gao LY; Sun WX; Hua Y; Yang SB; Zhang ZP; Liao GY; Zhou QG; Luo CX; Zhu DY
Eur J Pharmacol; 2014 Oct; 740():522-31. PubMed ID: 24975100
[TBL] [Abstract][Full Text] [Related]
79. Edaravone: a new therapeutic approach for the treatment of acute stroke.
Kikuchi K; Kawahara K; Miyagi N; Uchikado H; Kuramoto T; Morimoto Y; Tancharoen S; Miura N; Takenouchi K; Oyama Y; Shrestha B; Matsuda F; Yoshida Y; Arimura S; Mera K; Tada K; Yoshinaga N; Maenosono R; Ohno Y; Hashiguchi T; Maruyama I; Shigemori M
Med Hypotheses; 2010 Dec; 75(6):583-5. PubMed ID: 20728280
[TBL] [Abstract][Full Text] [Related]
80. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters.
Edaravone Acute Infarction Study Group
Cerebrovasc Dis; 2003; 15(3):222-9. PubMed ID: 12715790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
